Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: A randomized trial for treatment of hazardous substance use in pregnancy and after delivery

General Hospital Psychiatry

Volumn 34, Issue 5, 2012, Pages 439-449

  Yonkers, Kimberly A ^a   Forray, Ariadna ^a   Howell, Heather B ^a   Gotman, Nathan ^a   Kershaw, Trace ^a   Rounsaville, Bruce J ^a   Carroll, Kathleen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol abuse; Alcohol dependence; Behavioral treatment; Drug abuse; Drug dependence; Postpartum; Pregnancy

Indexed keywords

ADOLESCENT; ALCOHOL ABUSE; ARTICLE; BEHAVIOR THERAPY; BRIEF ADVICE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOTIVATIONAL ENHANCEMENT THERAPY COUPLED WITH COGNITIVE BEHAVIORAL THERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SUBSTANCE ABUSE; THERAPY EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COUNSELING; FEMALE; HUMANS; MOTIVATION; PREGNANCY; PREGNANCY COMPLICATIONS; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84865376835     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2012.06.002     Document Type: Article

References (61)

1. SAMHSA Results from the 2007 National Survey on Drug Use and Health: national findings 2007, 1-290. Office of Applied Studies, Rockville, MD.
2. Ebrahim S.H., Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003, 101(2):374-379.
3. Lui S., Terplan M., Smith E.J. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database Syst Rev 2008, (3):CD006753.
4. Terplan M., Lui S. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database Syst Rev 2008, (4):CD006037.
5. Jones H.E., O'Grady K.E., Tuten M. Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. Am J Addict 2011, 20(3):196-204.
6. Schottenfeld R.S., Moore B., Pantalon M.V. Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children. Drug Alcohol Depend 2011, 118(1):48-55.
7. Silverman K., Svikis D., Robles E., Stitzer M.L., Bigelow G.E. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp Clin Psychopharmacol 2001, 9(1):14-23.
8. Svikis D.S., Lee J.H., Haug N.A., Stitzer M.L. Attendance incentives for outpatient treatment: effects in methadone and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 1997, 48:33-41.
9. Jones H.E., Haug N.A., Stitzer M.L., Svikis D.S. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives. Addict Behav 2000, 25(2):263-267.
10. Jones H.E., Haug N., Silverman K., Stitzer M., Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 2001, 61:297-306.
11. Elk R., Schmitz J., Manfredi L., Rhoades H., Andres R., Grabowski J. Cessation of cocaine use during pregnancy: a preliminary comparison. Addict Behav 1994, 19(6):697-702.
12. Carroll K.M., Chang G., Behr H., Clinton B., Kosten T.R. Improving treatment outcome in pregnant, methadone-maintained women: results from a randomized clinical trial. Am J Addictions 1995, 4(1):56-59.
13. Heil S.H., Higgins S.T., Bernstein I.M., Solomon L.J., Rogers R.E., Thomas C.S., Badger G.J., Lynch M.E. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 2008, 103(6):1009-1018.
14. Higgins S.T., Bernstein I.M., Washio Y., Heil S.H., Badger G.J., Skelly J.M., Higgins T.M., Solomon L.J. Effects of smoking cessation with voucher-based contingency management on birth outcomes. Addiction 2010, 105(11):2023-2030.
15. O'Neil K., Baker A., Cooke M., Collins E., Heather N., Wodak A. Evaluation of a cognitive-behavioral intervention for pregnant injecting drug users at risk of HIV infection. Addiction 1996, 91(8):115-1125.
16. Winhusen T., Kropp F., Babcock D., Hague D., Erickson S.J., Renz C., Rau L., Lewis D., Leimberger J., Somoza E. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat 2008, 35(2):161-173.
17. Haug N.A., Svikis D.S., Diclemente C. Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychol Addict Behav 2004, 18(3):289-292.
18. Mullins M., Suarez M., Ondersma S., Page M. The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat 2004, 27:51-58.
19. Jones H.E., Svikis D.S., Tran G. Patient compliance and maternal/infant outcomes in pregnant drug-using women. Subst Use Misuse 2002, 37(11):1411-1422.
20. Handmaker N.S., Miller W.R., Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Studies on Alcohol. 1999, 60(2):285.
21. Rosett H.L., Weiner L., Edelin K.C. Treatment experience with pregnant problem drinkers. JAMA 1983, 249(15):2029-2033.
22. O'Connor M.J., Whaley S.E. Brief intervention for alcohol use by pregnant women. Am J Public Health 2007, 97(2):252-258.
23. Chang G., Wilkins-Haug L., Berman S., Goetz M.A. Brief intervention for alcohol use in pregnancy: a randomized trial. Addiction 1999, 94(10):1499-1508.
24. Chang G., Goetz M.A., Wilkins-Haug L., Berman S. A brief intervention for prenatal alcohol use: an in-depth look. J Subst Abuse Treat 2000, 18(4):365-369.
25. Chang G., McNamara T., Orav J., Koby D., Lavigne A., Ludman B., Vincitorio N., Wilkins-Haug L. Brief intervention for prenatal alcohol use: a randomized trial. Obstet Gynecol 2005, 105(5):991-998.
26. Armstrong M.A., Lieberman L., Carpenter D.M., Gonzales V.M., Usatin M.S., Newman L., Escobar G.J. Early start: an obstetric clinic-based, perinatal substance abuse intervention program. Qual Manag Health Care 2001, 9(2):6-15.
27. Lejeune C., Floch-Tudal C., Crenn-Hebert C., Simonpoli A.M. Groupe d'Etudes Grossesse et A. [Perinatal drug abuse. Collaborative perinatal care for drug abusers and their infants]. J Gynecol Obstet Biol Reprod (Paris) 2004, 33(1 Suppl):S67-S70.
28. Ebrahim S.H., Diekman S.T., Floyd R.L., Decoufle P. Comparison of binge drinking among pregnant and nonpregnant women, United States, 1991-1995. Am J Obstet Gynecol 1999, 181(1):1-7.
29. Moore D.G., Turner J.D., Parrott A.C., Goodwin J.E., Fulton S.E., Min M.O., Fox H.C., Braddick F.M.B., Axelsson E.L., Lynch S., Ribeiro H., Frostick C.J., Singer L.T. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J Psychopharmacolo. 2010, 24(9):1403-1410.
30. Irvin J.E., Bowers C.A., Dunn M.E., Wang M.C. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999, 67(4):563-570.
31. Babor T.F., Carroll K., Christiansen K., Kadden R., Litt M., McRee B., Miller M., Roffman R., Solowij N., Steinberg K., Stephens R., Vendetti J., Donaldson J., Herrell J. Brief treatments for cannabis dependence: findings from a randomized multi-site trial. Consulting Psychol 2004.
32. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., Rounsaville B.J. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 2004, 61:264-272.
33. Chang G, Wilkins-Haug L, Berman S, Goetz M. The TWEAK: Application in a prenatal setting. Brigham and Women's Hospital, Boston, & Department of Psychiatry, Harvard Medical School. 1999;60:306-9.
34. Russell M. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health 1996, 86(10):1435-1439.
35. Yonkers Screening for prenatal substance use: development of the substance use risk profile-pregnancy scale. Obstet Gynecol 2010, 116(4):827-833.
36. Miller W., Rolnick Motivational interviewing: preparing people to change addictive behavior 1991, Guilford Press.
37. Miller WR, Zweben A, DiClemente CC, Rychtarik RG. Motivational enhancement therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: unpublished manuscript; 1992.
38. Carroll K., Ball S., Martino S. Cognitive, behavioral, and motivational therapies. The American Psychiatric Publishing textbook of substance abuse treatment 2004, 365-376. American Psychiatric Publishing, Washington, DC. 3 ed. M. Galanter, H. Kleber (Eds.).
39. Parsons J., Rosof E., Punzalan J., Di Maria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDS 2005, 19(1):31-39.
40. Monti P.M., Kadden R.M., Rohsenow D.J., Cooney N.L., Abrams D.B. Treating alcohol dependence: a coping skills training guide 2002, The Guilford Press, New York, NY. 2nd ed.
41. Kadden R., Carrol K., Donovan D., Cooney N., Monti P., Abram D., Litt M., Hester R. Cognitive-behavioral coping skills therapy manual: a clinical research guide for therapits treating individuals with alcohol abuse and dependence. NIAAA Project MATCH monograph series (Vol3, DHHS Publication No ADM 92-1895) 1992, U.S. Government Printing Office, Washington, DC. M.E. Mattson (Ed.).
42. Yonkers K.A., Howell H.B., Allen A.E., Ball S.A., Pantalon M.V., Rounsaville B.J. A treatment for substance abusing pregnant women. Arch Women's Mental Health 2009, 12(4):221-227.
43. Carroll K.M., Nich C., Sifry R.L., Nuro K.F., Frankforter T.L., Ball S.A., Fenton L., Rounsaville B.J. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend 2000, 57:225-238.
44. Sheehan D., Lecrubier Y., Sheehan K., Amorim P., Janava J., Weiller E., Hergueta T., Baker R., Dunbar G. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr 1998, 59(S20):22-33.
45. Falsetti S., Resnick H., Pesick P., Kilpatrick D. The modified PTSD symptom scale: a brief self-report measure of posttraumatic stress disorder. Behavior Therapist. 1993, 16:161-162.
46. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The Inventory of Depressive Symptomatology (IDS) psychometric properties. Psychol Med 1996, 26:477-486.
47. Sobell L., Sobell M. Timeline Follow-Back: a technique for assessing self-reported alcohol consumption. Measuring alcohol consumption: psychosocial and biological methods 1992, 41-72. Humana Press, Towota, NJ. R. Litten (Ed.).
48. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000, 68:134-144.
49. Kotelchuck M. The adequacy of prenatal care utilization index: its US distribution and association with low birthweight. Am J Public Health 1994, 84(9):1486-1489.
50. Anker J.J., Larson E.B., Gliddon L.A., Carroll M.E., Anker J.J., Larson E.B., Gliddon L.A., Carroll M.E. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp Clin Psychopharmacol 2007, 15(5):472-480.
51. Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E., Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E. Attenuation of cocaine-seeking by progesterone treatment in female rats. Psychoneuroendocrinology 2009, 34(3):343-352.
52. Larson E.B., Anker J.J., Gliddon L.A., Fons K.S., Carroll M.E. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Exp Clin Psychopharmacol 2007, 15(5):461-471.
53. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31(3):659.
54. Sofuoglu M., Babb D.A., Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav 2002, 72(1-2):431.
55. Sofuoglu M., Mitchell E., Mooney M., Sofuoglu M., Mitchell E., Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol 2009, 24(7):559-564.
56. Burke B.L., Arkowitz H., Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. [see comment]. J Consult Clin Psychol. 2003, 71(5):843-861.
57. Magill M., Ray L.A. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 2009, 70(4):516-527.
58. Lundahl B., Burke B.L. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol 2009, 65(11):1232-1245.
59. McHugh R.K., Hearon B.A., Otto M.W. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am 2010, 33(3):511-525.
60. Quesada O, Gotman N, Howell HB, Funai EF, Rounsaville BJ, Yonkers KA. Prenatal hazardous substance use and adverse birth outcomes. J Maternal-Fetal and Neonatal Medicine;0(0):1-6.
61. Yonkers K.A., Howell H.B., Gotman N., Rounsaville B.J. Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women. J Subst Use 2011, 16(5):372-380.